Skip to main content

and
Your search also matched 7 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes

Include preview-only content
  1. Article

    Open Access

    Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors

    [Cu(thp)4][PF6] (HydroCuP) is a phosphino copper(I) complex highly soluble and stable in physiological media that has been developed as a possible viable alternative to platinum-based drugs for anticancer therapy...

    Valentina Gandin, Cecilia Ceresa, Giovanni Esposito in Scientific Reports (2017)

  2. Article

    Open Access

    Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates

    We present the anticancer properties of cis, cis, trans-[Pt(IV)(NH3)2Cl2(OA)2] [Pt(IV)diOA] (OA = octanoato), Pt(IV) derivative of cisplatin containing two OA units appended to the axial positions of a six-coordi...

    Vojtech Novohradsky, Ilaria Zanellato, Cristina Marzano in Scientific Reports (2017)

  3. Article

    Open Access

    Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position

    The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely investigated approach to overcome the limitations of Pt(II) anticancer agents. A series of ten mono- and bis-c...

    Dina Tolan, Valentina Gandin, Liam Morrison, Ahmed El-Nahas in Scientific Reports (2016)

  4. Article

    Open Access

    Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N’-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily

    Kinase inhibitors are attractive drugs/drug candidates for the treatment of cancer. The most recent literature has highlighted the importance of multi target kinase inhibitors, although a correct balance betwe...

    Valentina Gandin, Alessandro Ferrarese, Martina Dalla Via in Scientific Reports (2015)